Navigation Links
Terumo Cardiovascular Systems Becomes Exclusive U.S. Distributor for TigerPaw® System II, Left Atrial Appendage Closure Device
Date:1/19/2012

ANN ARBOR, Mich., Jan. 19, 2012 /PRNewswire/ -- Terumo Cardiovascular Systems announced today that it has entered into an exclusive agreement with LAAx, Inc. to distribute the TigerPaw® System II, a left atrial appendage closure device in the U.S.

The TigerPaw System II is indicated for occlusion of the left atrial appendage under direct visualization, in conjunction with other open cardiac procedures.  It is new to the market following successful completion of a clinical trial.  During its clinical trial the TigerPaw System II provided 100% occlusion at both post-op and at 90 days.

Mark Sutter, President and CEO of Terumo Cardiovascular Systems, stated, "This expansion of our product portfolio is another example of Terumo CVS's commitment to the CV OR market.  The distribution agreement provides us with an excellent product that provides advantages over other offerings on the market and that cardiac surgeons need today.  We are proud of this new partnership with LAAx, Inc."

Bill Wheeler, President and CEO of LAAx, Inc., added, "Terumo's broad distribution network will be a tremendous asset.  We will work together to get the TigerPaw System II into the hands of cardiac surgeons who have not yet had access to a clinically proven, 100% occlusive left atrial appendage (LAA) closure device. This clinical outcome expectation will benefit patients who need to reduce the medical risks associated with a less than 100% closure of the LAA.  We are happy to offer that option. Risk mitigation is an important consideration for every cardiac surgeon who considers 100% occlusion to be the only acceptable medical outcome for LAA occlusion technologies."

About Terumo Cardiovascular Systems Corporation 
Terumo Cardiovascular Systems Corporation manufactures and markets medical devices for the global cardiac surgery market and is the U.S. distributor for Vascutek® Vascular G
'/>"/>

SOURCE Terumo Cardiovascular Systems
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Terumo Americas Holding Acquires Onset Medical Corporation, a Leader in Innovative Sheath Technology Designed for Multiple, Minimally Invasive Clinical Applications
2. Terumo Corporation, A Global Leader In Medical Device Technology, Celebrates 90th Anniversary
3. FDA Classifies Recent Terumo CVS Recall of Coronary Ostia Cannulae as Class I Action
4. Final Published Trial Data in The Lancet Supports Safety and Effectiveness of MicroVention-Terumos HydroCoil® Embolic System for Treatment of Cerebral Aneurysms
5. Terumo Cardiovascular Systems Reaches Agreement on Terms of Consent Decree With FDA Regarding Quality System Improvements
6. VirtuoSaph® Plus Endoscopic Vessel Harvesting System from Terumo Continues the Advancement of the Minimally Invasive Technique for Coronary and Peripheral Artery Bypass Grafting
7. Terumo To Simultaneously Evaluate Misago Self-Expanding Stent System in the United States and Japan
8. Terumo to Sponsor Presentations on Key Issues in Cardiac and Vascular Surgery at Society of Thoracic Surgeons Annual Meeting
9. Terumo Cardiovascular Systems Initiates U.S. Clinical Trial for Anaconda(TM) AAA Stent Graft System
10. Terumo Heart, Inc. Reaches Clinical Milestone as the 100th Patient Worldwide Receives the DuraHeart(TM) Left Ventricular Assist System
11. Terumo Heart, Inc. Reports Clinical Progress in the DuraHeart(TM) U.S. Pivotal Trial as NewYork-Presbyterian Hospital/Columbia University Medical Center Implants First Patient
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... , July 28, 2015 Research and Markets ... "Refurbished Medical Equipment Market - Global Forecasts to ... global refurbished medical equipment market is estimated to grow ... CAGR of 12.5% from 2014 to 2019. ... medical devices due to financial constraints, increasing privatization in ...
(Date:7/28/2015)... July 28, 2015 A German Diabetes Center ... L. reuteri probiotic enriches human gut microbiota and ... secretion.  The study involved daily administration of Nutraceutix,s ... using the patented BIO- tract ® delivery ... acid on their way to the intestinal tract. ...
(Date:7/28/2015)... July 28, 2015  SeraCare Life Sciences, a ... announced today at the American Association of Clinical ... licensing agreement with the University of California, San ... (T21), Trisomy 18 (T18) and Trisomy 13 (T13) ... creating "patient-like" reference materials for Non-Invasive Prenatal Testing ...
Breaking Medicine Technology:Refurbished Medical Equipment Market 2015 - Global Forecasts to 2019 2Nutraceutix's L. reuteri Probiotic Clinically Proven to Modulate Gut Insulin Metabolism 2SeraCare Life Sciences Signs License Agreement with UCSF and Announces Early Access Program for Development of Aneuploidy Reference Materials 2SeraCare Life Sciences Signs License Agreement with UCSF and Announces Early Access Program for Development of Aneuploidy Reference Materials 3
... Feb. 24, 2011 Reportlinker.com announces that a new ... Global Orthopedic Orthotics Industry ... the worldwide markets for Orthopedic Orthotics in US$ Million ... Ankle Braces, & Others) and Orthopedic Support Devices. The ...
... Sciences, Inc. (Nasdaq: CALP ), today announced ... the U.S. Environmental Protection Agency,s (EPA) ToxCast program have ... Key findings reported include (1) a high level of ... statistical analyses, and (2) the role that specific targets ...
Cached Medicine Technology:Reportlinker Adds Global Orthopedic Orthotics Industry 2Analysis of Caliper's Phase I EPA ToxCast™ Data Published in Leading Scientific Journal 2Analysis of Caliper's Phase I EPA ToxCast™ Data Published in Leading Scientific Journal 3
(Date:7/28/2015)... (PRWEB) , ... July 28, 2015 , ... According to ... able to stop the cycle of addiction in lab mice. The study involving isradipine ... for the new prospect of helping their clients overcome drug and alcohol addictions. The ...
(Date:7/28/2015)... ... July 28, 2015 , ... According to WFTV ... taking the lead among heroin toxicity cases. According to recent statistic Orlando suffers at ... become known as a hub of heroin, and law enforcement officials are struggling to ...
(Date:7/28/2015)... (PRWEB) , ... July 28, 2015 , ... ... the SmileCareClub Invisible Aligner System to its online product offerings, giving ... using a teledentistry model and cloud-based technology, SmileCareClub allows patients to get quality, ...
(Date:7/28/2015)... ... July 28, 2015 , ... A new ... workers than they are in the general population. Surviving Mesothelioma has just posted ... , Researchers at Taiwan’s National Health Research Institutes and three Taiwanese universities ...
(Date:7/28/2015)... ... 2015 , ... Fertility specialist Dr. Lisa Hasty of Atlanta Center ... Magazine. In Atlanta Magazine's annual Top Doctors issue, Dr. Hasty has been recognized for ... in the metro area as one of the most respected doctors in Reproductive Endocrinology. ...
Breaking Medicine News(10 mins):Health News:Blood Pressure Medication May be the Key to Treating Addiction 2Health News:Blood Pressure Medication May be the Key to Treating Addiction 3Health News:Heroin Overdose Deaths Increase by 270 Percent, Orlando Takes the Lead 2Health News:Heroin Overdose Deaths Increase by 270 Percent, Orlando Takes the Lead 3Health News:Brookstone Now Offers SmileCareClub Teeth Straightening System 2Health News:Brookstone Now Offers SmileCareClub Teeth Straightening System 3Health News:New Findings Suggest Mesothelioma is Not the Only Cancer Threat for Shipbreakers, According to Surviving Mesothelioma 2Health News:Atlanta Fertility Specialist Named Top Doctor in Atlanta Magazine 2Health News:Atlanta Fertility Specialist Named Top Doctor in Atlanta Magazine 3
... Incorporated,(Nasdaq: GPRO ) announced today that the Company ... Wednesday, January 9, 2008 at,approximately 3:30 p.m. Pacific Time ... webcast live and may be accessed through a,link on ... . The webcast will be available for 30 days,following ...
... former Officer of Aetna, Inc., LOVELAND, Colo., ... today announced that Ms. Louise McCormick has joined ... ), "We pride ourselves on our commitment ... of high quality, independent Directors,is critical to this ...
... Antibodies to Fight Fatal Disease, LYON, ... division of sanofi-aventis Group, announced today that ... agreement with,Crucell N.V. (Euronext, NASDAQ: CRXL) for ... to be used in,association with rabies vaccine ...
... after calling emergency hotlines , , WEDNESDAY, Jan. 2 (HealthDay ... infectious disease outbreak may find themselves on hold with ... a new phone survey finds. , That hold ... researchers could not get through on at least one ...
... doctors say sunitinib,s benefits outweigh its risks , , WEDNESDAY, ... sunitinib (Sutent) can cause high blood pressure in patients ... echoes the results of a study published last month ... risk of heart failure among patients with stomach cancer. ...
... to help the poor, some experts say, , , WEDNESDAY, Jan. ... wealthy and insured patients, not to the poor and uninsured ... fact, more than four-fifths of those who receive samples are ... one-third have low incomes (below $37,000 for a family of ...
Cached Medicine News:Health News:Gen-Probe to Webcast Presentation at 26th Annual JPMorgan Healthcare Conference 2Health News:Louise McCormick Joins Heska's Board of Directors 2Health News:Louise McCormick Joins Heska's Board of Directors 3Health News:Sanofi Pasteur Enters Agreement With Crucell for Next-Generation Biologicals Against Rabies 2Health News:Sanofi Pasteur Enters Agreement With Crucell for Next-Generation Biologicals Against Rabies 3Health News:Sanofi Pasteur Enters Agreement With Crucell for Next-Generation Biologicals Against Rabies 4Health News:Health Departments Slow to Respond to Disease Outbreaks 2Health News:New Cancer Drug Boosts Blood Pressure 2Health News:New Cancer Drug Boosts Blood Pressure 3Health News:Most Free Drug Samples Go to Wealthy and Insured 2Health News:Most Free Drug Samples Go to Wealthy and Insured 3
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: